209 related articles for article (PubMed ID: 15216456)
21. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
22. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1.
Dezzutti CS; Guenthner PC; Cummins JE; Cabrera T; Marshall JH; Dillberger A; Lal RB
J Infect Dis; 2001 Apr; 183(8):1204-13. PubMed ID: 11262202
[TBL] [Abstract][Full Text] [Related]
23. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV).
Canque B; Marandin A; Rosenzwajg M; Louache F; Vainchenker W; Gluckman JC
Virology; 1995 Apr; 208(2):779-83. PubMed ID: 7747451
[TBL] [Abstract][Full Text] [Related]
25. Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
Guan Y; Abdelwahab S; Kamin-Lewis R; DeVico AL; Lewis GK
PLoS One; 2008; 3(10):e3481. PubMed ID: 18941536
[TBL] [Abstract][Full Text] [Related]
26. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
Schweighardt B; Roy AM; Meiklejohn DA; Grace EJ; Moretto WJ; Heymann JJ; Nixon DF
J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712
[TBL] [Abstract][Full Text] [Related]
27. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
28. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G
Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774
[TBL] [Abstract][Full Text] [Related]
29. Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.
Peretti S; Schiavoni I; Pugliese K; Federico M
Virology; 2006 Feb; 345(1):115-26. PubMed ID: 16271741
[TBL] [Abstract][Full Text] [Related]
30. Primary human mammary epithelial cells endocytose HIV-1 and facilitate viral infection of CD4+ T lymphocytes.
Dorosko SM; Connor RI
J Virol; 2010 Oct; 84(20):10533-42. PubMed ID: 20702626
[TBL] [Abstract][Full Text] [Related]
31. Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission.
Groot F; van Capel TM; Schuitemaker J; Berkhout B; de Jong EC
Retrovirology; 2006 Aug; 3():52. PubMed ID: 16916447
[TBL] [Abstract][Full Text] [Related]
32. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection.
Kamiyama H; Yoshii H; Tanaka Y; Sato H; Yamamoto N; Kubo Y
Virology; 2009 Mar; 386(1):23-31. PubMed ID: 19178925
[TBL] [Abstract][Full Text] [Related]
33. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
[TBL] [Abstract][Full Text] [Related]
34. Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection.
Kubo Y; Yoshii H; Kamiyama H; Tominaga C; Tanaka Y; Sato H; Yamamoto N
Virology; 2008 May; 375(1):130-40. PubMed ID: 18295815
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
[TBL] [Abstract][Full Text] [Related]
36. Increased susceptibility to HIV-1 of peripheral blood lymphocytes in acute infection with Epstein-Barr virus.
Moriuchi M; Moriuchi H
J Med Virol; 2003 Nov; 71(3):343-6. PubMed ID: 12966538
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.
Binninger-Schinzel D; Müller D; Wolf T; Krause B; Meye B; Winskowsky G; Raupp S; Norley S; Brodt R; Werner A
J Med Virol; 2008 Feb; 80(2):192-200. PubMed ID: 18098144
[TBL] [Abstract][Full Text] [Related]
38. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
39. Selective transmission of R5-tropic HIV type 1 from dendritic cells to resting CD4+ T cells.
David SA; Smith MS; Lopez GJ; Adany I; Mukherjee S; Buch S; Goodenow MM; Narayan O
AIDS Res Hum Retroviruses; 2001 Jan; 17(1):59-68. PubMed ID: 11177384
[TBL] [Abstract][Full Text] [Related]
40. Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine.
Auvert B; Jenabian MA; Saidi H; Lissouba P; Bélec L
Arch Virol; 2011 Dec; 156(12):2181-6. PubMed ID: 21947506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
